ESMO Preceptorship on Lung Cancer 2024: Paris

15 - 16 Nov 2024

Paris, France

ESMO-Preceptorship-Lung-Cancer-1000x1000

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Meeting programme Next/upcoming meetings

Learning objectives

To learn about best clinical practice in the management of NSCLC in early, locally advanced, and metastatic stages
To learn about the management of patients with actionable driver alterations and novel targeted agents for advanced NSCLC
To understand the role of immune checkpoint blockade for lung cancer and to learn about novel immunotherapies
To learn about the systemic treatment of mesothelioma, SCLC and thymoma

This event has been supported by an unrestricted educational grant from AstraZeneca and BeiGene.

Hide

There are 29 resources available